Announcements
- Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
- Immuron Board Changes
- Immuron CEO Steven Lydeamore to present at Peak Sky High
- Immuron Limited to Present at the Emerging Growth Conference
- Immuron Director Resignation
- Immuron to host Live Virtual Event
- Immuron Travelan® sales continued strong growth
- Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
- Immuron Presentation Australian Biologics Festival 2024
- Immuron achieves record Travelan® sales
More ▼
Key statistics
As of last trade Immuron Ltd (ANWA:DUS) traded at 2.06, 9.57% above its 52-week low of 1.88, set on May 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.06 |
---|---|
High | 2.06 |
Low | 2.06 |
Bid | 2.06 |
Offer | 2.26 |
Previous close | 2.10 |
Average volume | 0.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jun 06 2024 11:30 BST.
More ▼